BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29108900)

  • 1. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
    Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
    Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
    Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
    IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of serum irisin level with metabolic and antropometric parameters in obese children.
    Çatlı G; Küme T; Tuhan HÜ; Anık A; Çalan ÖG; Böber E; Abacı A
    J Diabetes Complications; 2016; 30(8):1560-1565. PubMed ID: 27539885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.
    Marita AR; Sarkar JA; Rane S
    Mol Cell Biochem; 2005 Jul; 275(1-2):143-51. PubMed ID: 16335794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin levels in LMNA-associated partial lipodystrophies.
    Bensmaïne F; Benomar K; Espiard S; Vahe C; Le Mapihan K; Lion G; Lemdani M; Chazard E; Ernst O; Vigouroux C; Pigny P; Vantyghem MC
    Diabetes Metab; 2019 Jan; 45(1):67-75. PubMed ID: 30165155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis.
    Reinehr T; Elfers C; Lass N; Roth CL
    J Clin Endocrinol Metab; 2015 May; 100(5):2123-30. PubMed ID: 25781361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower circulating irisin is associated with type 2 diabetes mellitus.
    Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
    J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patients.
    Aly O; Zaki HH; Herzalla MR; Fathy A; Raafat N; Hafez MM
    PLoS One; 2020; 15(6):e0234465. PubMed ID: 32544194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irisin levels in the progression of diabetes in sedentary women.
    Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
    Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk.
    Bonfante ILP; Chacon-Mikahil MPT; Brunelli DT; Gáspari AF; Duft RG; Oliveira AG; Araujo TG; Saad MJA; Cavaglieri CR
    Arch Endocrinol Metab; 2017 Dec; 61(6):524-533. PubMed ID: 29412381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.
    Saadeldin MK; Elshaer SS; Emara IA; Maged M; Abdel-Aziz AK
    PLoS One; 2018; 13(11):e0206761. PubMed ID: 30403705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of irisin, retinol-binding protein 4, and leptin serum levels as biomarkers of macrovascular complications involvement in Saudi type 2 diabetes mellitus. A case-control study.
    Ali EY; Hegazy GA; Hashem EM
    Saudi Med J; 2020 Dec; 41(12):1369-1374. PubMed ID: 33294897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents.
    Quiñones M; Folgueira C; Sánchez-Rebordelo E; Al-Massadi O
    Mediators Inflamm; 2015; 2015():620919. PubMed ID: 26568663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
    Liu J; Hu Y; Zhang H; Xu Y; Wang G
    J Diabetes Complications; 2016; 30(8):1555-1559. PubMed ID: 27503404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Levels of Serum Irisin as a Predictor of Insulin Resistance in Han Chinese Adults with Metabolically Healthy Obesity.
    Liu BW; Yin FZ; Qi XM; Fan DM; Zhang Y
    Clin Lab; 2017 May; 63(5):881-886. PubMed ID: 28627815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5.
    Li B; Yao Q; Guo S; Ma S; Dong Y; Xin H; Wang H; Liu L; Chang W; Zhang Y
    Clin Exp Hypertens; 2019; 41(7):645-650. PubMed ID: 30307757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
    Panarotto D; Ardilouze JL; Tessier D; Maheux P
    Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study.
    Liu W; Zhou X; Li Y; Zhang S; Cai X; Zhang R; Gong S; Han X; Ji L
    Medicine (Baltimore); 2020 Feb; 99(6):e19052. PubMed ID: 32028423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2.
    Al-Daghri NM; Alokail MS; Rahman S; Amer OE; Al-Attas OS; Alfawaz H; Tripathi G; Sabico S; Chrousos GP; McTernan PG; Piya MK
    Eur J Clin Invest; 2015 Aug; 45(8):775-81. PubMed ID: 26011590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.